These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 8943063

  • 1. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines.
    Kinter AL, Ostrowski M, Goletti D, Oliva A, Weissman D, Gantt K, Hardy E, Jackson R, Ehler L, Fauci AS.
    Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):14076-81. PubMed ID: 8943063
    [Abstract] [Full Text] [Related]

  • 2. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha.
    Casoli C, Vicenzi E, Cimarelli A, Magnani G, Ciancianaini P, Cattaneo E, Dall'Aglio P, Poli G, Bertazzoni U.
    Blood; 2000 May 01; 95(9):2760-9. PubMed ID: 10779418
    [Abstract] [Full Text] [Related]

  • 3. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.
    Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, Fauci AS.
    Proc Natl Acad Sci U S A; 1996 Dec 24; 93(26):15341-5. PubMed ID: 8986813
    [Abstract] [Full Text] [Related]

  • 4. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
    Saha K, Bentsman G, Chess L, Volsky DJ.
    J Virol; 1998 Jan 24; 72(1):876-81. PubMed ID: 9420304
    [Abstract] [Full Text] [Related]

  • 5. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
    Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A, Sozzani S, Mantovani A, Poli G.
    J Leukoc Biol; 2000 Sep 24; 68(3):405-12. PubMed ID: 10985258
    [Abstract] [Full Text] [Related]

  • 6. CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta.
    Leith JG, Copeland KF, McKay PJ, Richards CD, Rosenthal KL.
    AIDS; 1997 Apr 24; 11(5):575-80. PubMed ID: 9108938
    [Abstract] [Full Text] [Related]

  • 7. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
    Jennes W, Sawadogo S, Koblavi-Dème S, Vuylsteke B, Maurice C, Roels TH, Chorba T, Nkengasong JN, Kestens L.
    AIDS Res Hum Retroviruses; 2002 Feb 10; 18(3):171-7. PubMed ID: 11839151
    [Abstract] [Full Text] [Related]

  • 8. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Pierdominici M, Giovannetti A, Ensoli F, Mazzetta F, Marziali M, De Cristofaro MR, Santini-Muratori D, Leti W, Aiuti F.
    J Acquir Immune Defic Syndr; 2002 Feb 01; 29(2):122-31. PubMed ID: 11832680
    [Abstract] [Full Text] [Related]

  • 9. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
    Giovannetti A, Ensoli F, Mazzetta F, De Cristofaro M, Pierdominici M, Muratori DS, Fiorelli V, Aiuti F.
    Clin Exp Immunol; 1999 Oct 01; 118(1):87-94. PubMed ID: 10540164
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.
    Jansson M, Popovic M, Karlsson A, Cocchi F, Rossi P, Albert J, Wigzell H.
    Proc Natl Acad Sci U S A; 1996 Dec 24; 93(26):15382-7. PubMed ID: 8986820
    [Abstract] [Full Text] [Related]

  • 13. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G, Bovolenta C, Rigamonti L, Borghi I, Altare F, Jouanguy E, Forni G, Casanova JL, Sherry B, Mengozzi M, Trinchieri G, Poli G, Gerosa F, Novelli F.
    J Leukoc Biol; 2002 Oct 24; 72(4):735-42. PubMed ID: 12377943
    [Abstract] [Full Text] [Related]

  • 14. Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects.
    Rubbert A, Weissman D, Combadiere C, Pettrone KA, Daucher JA, Murphy PM, Fauci AS.
    AIDS Res Hum Retroviruses; 1997 Jan 01; 13(1):63-9. PubMed ID: 8989428
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS.
    J Clin Invest; 1998 Jul 01; 102(1):223-31. PubMed ID: 9649576
    [Abstract] [Full Text] [Related]

  • 18. A comparative investigation of CC chemokines and SIV suppressor factors generated by CD8+ and CD4+ T cells and CD14+ monocytes.
    Babaahmady K, Bergmeier LA, Whittall T, Singh M, Wang Y, Lehner T.
    J Immunol Methods; 2002 Jun 01; 264(1-2):1-10. PubMed ID: 12191503
    [Abstract] [Full Text] [Related]

  • 19. Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production.
    Greco G, Barker E, Levy JA.
    AIDS Res Hum Retroviruses; 1998 Nov 01; 14(16):1407-11. PubMed ID: 9824318
    [Abstract] [Full Text] [Related]

  • 20. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
    De Luca A, Giancola ML, Cingolani A, Ammassari A, Murri R, Antinori A.
    AIDS Res Hum Retroviruses; 2000 Jun 10; 16(9):835-43. PubMed ID: 10875609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.